Product analysis
NAD+ Cell Regenerator offers a focused nicotinamide riboside supplement at a moderate cost.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The precise nutrient form is not fully identified in the ingredient description. That limits a direct comparison of form quality with other options.
Ingredient Transparency63
The declared nutrient amount is identified, but the ingredient form is unspecified. The description therefore makes quantity clearer than the precise preparation.
Value For Money60
The serving offers moderate value for its cost. It is reasonably priced rather than especially inexpensive.
Customer Satisfaction88
Customer ratings are very positive across thousands of reviews. That gives a broad picture of satisfaction without establishing cardiovascular benefits.
Product Focus30
The single-ingredient formula is focused, but its contribution to heart support remains uncertain. The serving has no established connection to the relevant cardiovascular measurements.
- Format
Capsule - Container
- 30 Capsule(s)
- Per serving
- $1.35
- Also available
NAD+ Cell Regenerator 100 mg$18.00- Customer rating
- 4.7 · 4,163 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
NIAGEN Nicotinamide Riboside | 300 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Niacin Form & Goal Alignment
Precursor Source Quality
Dose, Safety & Label Transparency92
Clarity of Chemical Form
Form-Specific Dosage Efficacy
Flush Risk & Safety Labeling
Value60
Price Per Effective Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
- Effects of niacin on apo A1 and B levels: a systematic review and meta-analysis of randomised controlled trials.
- Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials.
- Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
- Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.
- Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I.
- The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.
- The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome.
- Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.
- Effect of niacin on endothelial function: a systematic review and meta-analysis of randomized controlled trials.
- The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.
- Niacinamide: A B vitamin that improves aging facial skin appearance.
- The clinical anti-aging effects of topical kinetin and niacinamide in Asians: a randomized, double-blind, placebo-controlled, split-face comparative trial.
- A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
- Nicotinamide for Skin Cancer Chemoprevention.